| Income Statement | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|
| Loss on debt extinguishment | 0 | - | - | |
| Recovery of previously written off receivables | - | 50,000 | - | |
| Gain on sale of subsidiary assets | 0 | - | - | |
| Total other income (expense) | -25,996 | 27,340 | -34,377 | |
| Net loss from continuing operations before income taxes | -562,023 | -641,822 | - | |
| Provision for income taxes | 0 | - | - | |
| Net loss from continuing operations | -562,023 | -641,822 | -1,339,641 | |
| Net income from discontinued operations, net of taxes | 0 | - | - | |
| Net income (loss) | -562,023 | -641,822 | -1,339,641 | |
| Net income (loss) per share basic | 0 | -0.01 | -0.01 | |
| Net income (loss) per share diluted | 0 | -0.01 | -0.01 | |
| Weighted average number of common shares outstanding basic | 136,951,495 | 131,081,825 | 124,617,477 | |
| Weighted average number of common shares outstanding fully diluted | 136,951,495 | 131,081,825 | 124,617,477 | |
Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. (FUNI)